Clinical Trial

A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer

Study acronym: AK104-305
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated August 13, 2024 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is to evaluate the efficacy and safety of AK104 plus concurrent chemoradiotherapy compared to placebo plus concurrent chemoradiotherapy in participants with locally advanced cervical cancer
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-02-10; most recent amendment 2024-08-12.
Status change: Recruiting → Active, Not Recruiting 2024-08-12
Status change: Not Yet Recruiting → Recruiting 2022-08-22
Trial Details
NCT Number NCT05235516
Lead Sponsor Akeso
Conditions Locally Advanced Cervical Carcinoma
Enrollment 636 participants
Start Date 2022-06-21
Primary Completion 2026-05 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2024-08-13